PACIFIC BIOLABS

Company Snapshot

Founded: 1972
Entity Type: Public
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 551 Linus Pauling Drive, Hercules, California 94547 U.S. Tel. +1-510-964-9000 www.pacificbiolabs.com

Company Overview

Pacific BioLabs is a contract research organization (CRO) that provides testing and development services. It was established in 1982 as Northview Pacific Labs, the West Coast section of Northview Biosciences Inc. The original company was founded in 1972 by Martin Spalding as Northview Biosciences. Northview Pacific Labs was opened to support the biotech industry’s growing demands and offer animal services for Northview’s national and international clients. The company was initially located in Berkeley. In 2000, the company moved its operations to a new facility in Hercules, California. In 2006, Northview Biosciences sold its facilities in Northbrook, Illinois, and Spartanburg, S.C., to SGS. The company serves a range of industries, including the pharmaceutical, biotech, and medical device sectors. Pacific BioLabs acquired Bay Bioanalytical Laboratory in 2012 to expand its ability to serve various industries.

Pacific BioLabs is FDA registered. It is an ISO 17025:2017 accredited testing lab certified for microbiology, in vivo, and analytical chemistry testing services. Pacific BioLabs maintains affiliations with numerous professional associations, including:

  • American Society for Microbiology (ASM)
  • Association for the Advancement of Medical Instrumentation (AAMI)
  • Parenteral Drug Association (PDA)
  • Society for Industrial Microbiology (SMI)
  • Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC)
  • American Association for Laboratory Animal Science (AALAS)
  • American College of Toxicology (ACT)
  • American Association of Pharmaceutical Scientists (AAPS)
  • American Cancer Society
  • Pharmaceutical & BioScience Society International (PBSS) 

PACIFIC BIOLABS In Reports

Global Bioanalytical Testing Services Market

BCC Research's report on the global bioanalytical testing services market provides a comprehensive analysis of market trends, using 2022 as the base year and forecasting 2023 through 2028 with a CAGR projection.

Outsourcing Market for Drug and Medical Device Development: Services and Technologies

Global outsourcing services market for drug and medical device development is expected to grow from 130.5 billion pounds in 2020 to 205.6 billion pounds by 2025 with a CAGR of 9.5% for the period of 2020-2025.

GxP/GMP Regulation Testing, Services Market in Food, Pharmaceuticals, Medical Devices, and Cosmetics

The global GxP/GMP regulation testing market was valued at $7.6 billion in 2018, and is expected to reach sales of $14.2 billion in 2024, rising at a CAGR of 11.8% from 2019 to 2024.

Company's Business Segments

  • Life Science Testing : This segment includes Biopharm Manufacturing Support, Biopharm Drug Development Testing, Clinical Trial Support, Medical Device Tests, In-Vitro Services.

Applications/End User Industries

  • Physicians
  • Testing
  • Research
  • Clinical Trials
  • Healthcare
  • Current Good Manufacturing Practice (cGMP)
  • Good Laboratory Practice (GLP)
  • Biopharm Manufacturing
  • Biopharm Drug Development Testing
  • In Vitro Services
AI Sentiment